Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Personalised Cancer Vaccines: Tailored Immunotherapy for Precision Treatment
We take a look at what personalised cancer vaccines are, how they are developed, and how they are changing the field of immunotherapy.
Oligo Chemistry
The Growing Potential for Antisense Oligonucleotide Therapy
Antisense oligonucleotides hold major promise in future patient treatment approaches. Through targeting RNA to regulate protein expression, they can help to address diseases at their source and advance therapeutic outcomes.
Tumour Microenvironment
Spotlight on Padmanee Sharma: Conquering Cancer through Resilience and Innovation
Highlighting the exceptional contributions of Padmanee Sharma, whose unyielding determination led her to become a renowned physician and immunologist, reshaping the landscape of cancer research.
Drug Discovery & Development
NK Cell Therapies: Development, Application, and Challenges
Sourcing NK cells, expansion techniques, gene modification, quality control, safety, preservation, and delivery.
Stem Cell Therapy
Wiping an iPS Cell's Epigenetic Memory With TNT
Transient-native-transient reprogramming enables researchers to sidestep the differentiation quirks which can complicate the use of induced pluripotent stem cells by resetting their epigenetic memory.
Bioanalysis
Biologics Market Trends and Predictions: New Horizons Beckon
Here, we outline some of the main trends anticipated in market growth and development for biologics in the next few years. The global biologics market is predicted to exceed $600bn by 2032, driven by demand for personalised treatments for chronic diseases.
Immuno-Oncology
iBio Reports Antibody Hat-Trick in its In Vivo IO Programs
Significant progress in iBio's in vivo preclinical programs with positive data from three antibody candidates: anti-EGFRvIII, CCR8, and TROP-2 x CD3.
Biomarkers & Precision Medicine
Exploring Oncology Biomarkers in Early Clinical Trials and Precision Medicine: Challenges and Opportunities
The importance of validating hypotheses, understanding the biology of cancer progression, and utilising biomarkers in early screening to stratify populations and improve clinical endpoints.
Stem Cell Therapy
Lipid Found in Breast Milk May Reduce Cerebral Palsy in Infants
A study from Duke University found that a lipid present in breast milk promotes a process leading to the generation of new brain cells, which could potentially aid in the repair of damaged white matter in infants with cerebral palsy.
Immuno-Oncology
Using Mouse Models for Preclinical Immuno Oncology
Unveiling advancements in preclinical immuno-oncology: Exploring humanized mouse models and human knock-in mice for targeted cancer therapies.